Please login to the form below

Not currently logged in
Email:
Password:

Dedicated

This page shows the latest Dedicated news and features for those working in and with pharma, biotech and healthcare.

FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications

FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications

We intend to replicate our Udenyca achievements with a dedicated retina commercial team eager to leverage their experience and in-depth market understanding to drive Cimerli share.”.

Latest news

More from news
Approximately 0 fully matching, plus 464 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 106 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 56 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 219 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 950 experts delivering world-class...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...